Literature DB >> 9225305

[3H]raclopride binding to brain tissue from subjects with schizophrenia: methodological aspects.

B Dean1, G Pavey, K Opeskin.   

Abstract

The binding of [3H]raclopride to particulate membrane and frozen sections (with quantitative autoradiography) from the caudate-putamen, obtained at autopsy from schizophrenic and non-schizophrenic subjects, was measured. The affinity of [3H]raclopride to particulate membrane was significantly decreased in the schizophrenic compared to non-schizophrenic subjects. The density of [3H]raclopride binding to tissue from subjects with schizophrenia was increased, unchanged or decreased depending on the methodology used. Finally, there was an age-dependent decrease in [3H]raclopride binding in the frozen sections from the caudate-putamen of the non-schizophrenic subjects. This age-dependent decrease was not apparent using particulate membrane from schizophrenic or non-schizophrenic subjects or tissue sections from the schizophrenic subjects. We conclude that the binding of [3H]raclopride is dependent on methodology and therefore data from in vitro and in vivo studies using this drug should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225305     DOI: 10.1016/s0028-3908(97)00067-1

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

Review 1.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

2.  Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.

Authors:  Gursharan Chana; Chad A Bousman; Tammie T Money; Andrew Gibbons; Piers Gillett; Brian Dean; Ian P Everall
Journal:  Front Cell Neurosci       Date:  2013-06-26       Impact factor: 5.505

3.  Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia.

Authors:  Shaun Hopper; Geoffrey Mark Pavey; Andrea Gogos; Brian Dean
Journal:  Int J Neuropsychopharmacol       Date:  2019-10-01       Impact factor: 5.176

4.  Mu opioid receptor availability in people with psychiatric disorders who died by suicide: a case control study.

Authors:  Elizabeth Scarr; Tammie Terese Money; Geoffrey Pavey; Jaclyn Neo; Brian Dean
Journal:  BMC Psychiatry       Date:  2012-08-28       Impact factor: 3.630

5.  Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA.

Authors:  E Scarr; J M Craig; M J Cairns; M S Seo; J C Galati; N J Beveridge; A Gibbons; S Juzva; B Weinrich; M Parkinson-Bates; A P Carroll; R Saffery; B Dean
Journal:  Transl Psychiatry       Date:  2013-02-19       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.